Private equity firm Trilantic Capital Partners has agreed to purchase a substantial minority interest in Fortitech, a developer and manufacturer of nutrient premixes for the food, beverage and pharmaceutical industries.
Fortitech custom nutrient premixes integrate functional ingredients such as vitamins, minerals and amino acids into a wide range of products including cereals, dairy products, sports drinks, juices, water, baby formulas and snacks.
Headquartered in New York, Fortitech has facilities in the US, Europe, Asia, Mexico and South America.
This investment enables Fortitech to continue to drive its growth initiative.
“Fortitech is the leader in its industry, with a strong competitive position, experienced management team and attractive growth characteristics,” says Charlie Moore, partner at Trilantic Capital Partners. “Our partnership with Fortitech complements our existing portfolio of businesses that serve consumer end markets and further highlights our focus on providing institutional capital to founder-run businesses. We look forward to partnering with this outstanding team, which is led by a true entrepreneur.”
Walter S. Borisenok, president and co-founder of Fortitech, adds: “Trilantic’s investment provides us with the capital to help us realise our full growth potential and will support our continued expansion in global markets. Our partnership with Trilantic will allow us to enhance our leadership position in the fast-growing market for fortified and functional food, beverage and pharmaceutical products.”
Terms of the transactions were not disclosed.
